Chemical Compound

(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate

CAS Registry Number 61379-65-5
返回搜索 申请报价
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate 结构式
Primary record

(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate

库存
3,028 克
纯度
99.3 %
CAS
61379-65-5

化合物标识与属性

CAS
61379-65-5
PubChem CID
135403821
SMILES
C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C
Canonical SMILES
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C

名称与同义词

  • RIFAPENTINE
  • Priftin
  • Rifapentin
  • Rifapentina
  • Prifitin
  • Cyclopentylrifampicin
  • Rifapentinum
  • rifampin
  • Rifamycin AF/ACPP
  • Rifapex
  • 61379-65-5
  • Cyclopentyl rifampin
  • Priftin (TN)
  • MDL 473
  • Rifapentinum [Latin]
  • Rifapentina [Spanish]
  • KTC-1
  • MDL-473
  • Rifampicin S-Na Sodium
  • Antibiotic DL 473IT
  • RefChem:57295
  • Rifapentine Hydrochloride
  • RIFAPENTINE [MI]
  • KTC 1
  • MDL473
  • RIFAPENTINE [INN]
  • XJM390A33U
  • Rifapentine (USAN/INN)
  • ANTIBIOTIC DL-473IT
  • DTXSID8041115
  • MFCD00866806
  • RIFAPENTINE [USAN]
  • CHEBI:45304
  • RIFAPENTINE [VANDF]
  • CHEMBL1660
  • RIFAPENTINE [MART.]
  • UNII-XJM390A33U
  • DL 473
  • DL-473
  • SCHEMBL41590
  • RIFAPENTINE [WHO-DD]
  • DL 473;Cyclopentylrifampicin
  • Rifapentine [USAN:INN:BAN]
  • WDZCUPBHRAEYDL-GZAUEHORSA-N
  • DTXCID6021115
  • SCHEMBL29359039
  • SCHEMBL29913543
  • C47H64N4O12
  • DL 473-IT
  • GTPL12014
  • RIFAPENTINE [ORANGE BOOK]
  • DL473
  • HMS3713M16
  • R-773
  • DL-4-73
  • DRG-0283
  • 3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin
  • EINECS 262-743-9
  • BBF-03916
  • BDBM50248298
  • MSK158462
  • AKOS024255723
  • ACN-048196
  • AR27731
  • CCG-220467
  • DB01201
  • KS-1409
  • R-77-3
  • R773
  • SID:53787525
  • SY102391
  • CID:135403821
  • R 77-3
  • B2127
  • FT-0653692
  • C08059
  • D00879
  • J90035
  • [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
  • AB01209744-01
  • AB01209744-03
  • AB01209744_04
  • Rifamycin, 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)-
  • 3-[N-(4-Cyclopentyl-1-piperazinyl)formimidoyl]rifamycin
  • 379R655
  • A847176
  • C018421
  • M000473
  • Q3935297
  • 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin SV
  • 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)-rifamyci
  • 3-(4-Cyclopentyl-1-piperazinyl)iminomethylrifamycin SV
  • 3-(N-(4-Cyclopentyl-1-piperazinyl)formimidoyl)rifamycin
  • 3-[[(4-Cyclopentyl-1-piperazinyl)imino]methyl]rifamycin
  • 3-((4-CYCLOPENTYL-1-PIPERAZINYL)IMINO)METHYL)RIFAMYCIN
  • (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
  • RPT
  • ((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-((E)-(4-cyclopentylpiperazin-1-yl)iminomethyl)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl) acetate
  • (2R,16S,17R,18R,19R,20S,21S,22S,23S)-8-{[(4-CYCLOPENTYLPIPERAZIN-1-YL)IMINO]METHYL}-5,6,9,17,19-PENTAHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,11-DIOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA[1,11,13]TRIENOIMINO)NAPHTHO[2,1-B]FURAN-21-YL ACETATE
  • (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)-21-(Acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione
  • (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate
  • (7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,21Z)-26-((1E)-((4-cyclopentylpiperazin-1-yl)imino)methyl)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(28),2,4,9,19,21,23,25(29),26-nonaen-13-yl acetate
  • [[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-pentahydroxy-methoxy-heptamethyl-dioxo-[?]yl] acetate
  • 127923-87-9
  • 262-743-9
  • 3-[[(4-Cyclopentyl-1-piperazinyl)imino]methyl]-rifamycin; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; Antibiotic DL 473IT; Cyclopentylrifampicin; DL 473; KTC 1; MDL 473; Prifitin; Priftin; R 77-3; Rifamycin AF/ACPP; Rifapentin; Rifapentine
  • RPE